MedTrace Logo

Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative Care

NCT03463655 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-03-13

No results posted yet for this study

Summary

Current recommendations do not recommend the concomitant administration of albumin after ascites puncture in patients with ascites neoplasia unlike cirrhotic ascites. The etiology of ascites in cancer patients is multifactorial, particularly by hepatic invasion that can lead to ascites loaded with albumin. Ascites punctures therefore lead to undernutrition, recurrent early ascites by decreasing the oncotic pressure by hypo albuminemia and a state of anasarca affecting the quality of life.

Conditions

  • Solid Cancer in a Palliative Situation With Ascites

Interventions

DIAGNOSTIC_TEST

cirrhotic albumin

Ascites puncture

DIAGNOSTIC_TEST

serum albumin

blood punctures

Sponsors & Collaborators

  • Institut Paoli-Calmettes

    lead OTHER

Principal Investigators

  • Aurélien PROUX · Institut Paoli-Calmettes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-21
Primary Completion
2018-03-31
Completion
2018-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03463655 on ClinicalTrials.gov